Delivery Order SPE2DR25D2001-SPE2DR26FBFQ3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,609.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on November 17, 2025, with completion anticipated by November 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.73 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,635.72 to supply Trulicity 4.5 mg/0.5 ml pens on October 28, 2025, with a completion date of October 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units) under a firm fixed-price contract. The award, issued on October 23, 2025, carries a ceiling value of $1,738.55 and is set to be completed by October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,685.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on November 12, 2025, with completion expected by November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $23,573.76 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,874.31 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,744.44 with a firm fixed price contract structure. This delivery order is a non-set-aside competitive award with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-transaction purchase of the diabetes...
- The Defense Logistics Agency awarded a $5,814.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 2, 2025, with completion scheduled for December 3, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBFQ3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,143.02 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens (0.5 mL quantity) on November 25, 2025, with completion scheduled for November 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling value and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical supplies to support military healthcare programs and other federal health systems. Trulicity is a diabetes medication frequently procured through this contract vehicle to support the healthcare needs of the Defense Health Agency and other government medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 11/24/25 |